#3175
Secondary primary cancers and survival among neuroendocrine tumor patients
Introduction:
Higher rates of second cancer (SC) are suggested for patients with neuroendocrine tumors (NET), but data on SC are scare and their impact on outcomes is unknown.
Conference:
18th Annual ENETS Concerence (2021)
Presenting Author:
Bateni S
Authors:
Bateni S,
Coburn N,
Law C,
Singh S,
Myrehaug S,
Keywords:
neuroendocrine tumor,
secondary cancers,
survival,
gastrointestinal neuroendocrine tumor,
pancreatic neuroendocrine tumor,
pulmonary neuroendocrine tumor,
#2955
Development of an EORTC Quality of Life Questionnaire for Patients with Pancreatic Neuroendocrine Tumours: Phases 1-3
Introduction:
Measuring quality of life (QoL) in Pancreatic Neuroendocrine Tumours (pNET) involves assessing issues from symptoms, disease and treatment. The validated gastrointestinal NETs module (EORTC QLQ-GINET21) is used with EORTC QLQ-C30 but there are concerns it inadequately measures QoL in pNET.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Authors:
Friend E,
Gray D,
Fernández Ortega P,
McNamara M,
Kaltsas G,
Keywords:
research,
neuroendocrine,
insulinoma,
gastrinoma,
non-functioning,
VIPoma,
Glucagonoma,
questionnaire,
quality of life,